Alkermes Plc (ALKS)
47.03
+0.05
(+0.11%)
USD |
NASDAQ |
Nov 13, 16:00
47.02
-0.01
(-0.02%)
Pre-Market: 19:59
Alkermes Market Cap : 7.902B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 7.902B |
| November 12, 2026 | 7.894B |
| November 11, 2026 | 8.047B |
| November 10, 2026 | 7.808B |
| November 09, 2026 | 7.758B |
| November 06, 2026 | 7.713B |
| November 05, 2026 | 7.484B |
| November 04, 2026 | 7.711B |
| November 03, 2026 | 7.677B |
| November 02, 2026 | 7.543B |
| October 30, 2026 | 7.618B |
| October 29, 2026 | 7.601B |
| October 28, 2026 | 7.581B |
| October 27, 2026 | 7.425B |
| October 26, 2026 | 7.446B |
| October 23, 2026 | 7.310B |
| October 22, 2026 | 7.402B |
| October 21, 2026 | 7.285B |
| October 20, 2026 | 7.390B |
| October 19, 2026 | 7.199B |
| October 16, 2026 | 6.906B |
| October 15, 2026 | 6.718B |
| October 14, 2026 | 6.548B |
| October 13, 2026 | 6.656B |
| October 12, 2026 | 6.745B |
| Date | Value |
|---|---|
| October 09, 2026 | 6.804B |
| October 08, 2026 | 6.720B |
| October 07, 2026 | 6.944B |
| October 06, 2026 | 6.978B |
| October 05, 2026 | 7.164B |
| October 02, 2026 | 6.995B |
| October 01, 2026 | 6.792B |
| September 30, 2026 | 6.789B |
| September 29, 2026 | 6.836B |
| September 28, 2026 | 6.727B |
| September 25, 2026 | 6.844B |
| September 24, 2026 | 6.834B |
| September 23, 2026 | 7.059B |
| September 22, 2026 | 7.253B |
| September 21, 2026 | 7.402B |
| September 18, 2026 | 7.270B |
| September 17, 2026 | 7.826B |
| September 16, 2026 | 7.719B |
| September 15, 2026 | 7.712B |
| September 14, 2026 | 7.678B |
| September 11, 2026 | 7.702B |
| September 10, 2026 | 7.725B |
| September 09, 2026 | 7.606B |
| September 08, 2026 | 7.621B |
| September 04, 2026 | 7.724B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amarin Corp. Plc | 239.91M |
| Prothena Corp. Plc | 418.94M |
| Cue Biopharma, Inc. | 84.30M |
| ACADIA Pharmaceuticals, Inc. | 3.240B |
| Alnylam Pharmaceuticals, Inc. | 22.09B |
Market Cap Related Metrics
| PS Ratio | 4.597 |
| Price to Book Value | 4.238 |
| Price to Free Cash Flow | 35.45 |
| Price | 47.03 |
| Earnings Yield | -0.03% |
| Operating PE Ratio | 86.97 |
| Normalized PE Ratio | 465.64 |